GCC Biotech offers a range of molecular diagnostic solutions for the detection of sepsis-causing pathogens. Their GSure DNA isolation kits are designed to extract high-quality DNA from minimal sample volumes, ensuring purity and free from contaminants. These kits utilize a silica-based microspin format, optimized for various sample types, including blood, tissue, and serum, delivering DNA with an absorbance ratio of 260nm/280nm between 1.78-1.82, indicative of high purity. ​
For pathogen detection, GCC Biotech provides the DiAGSure® Bacterial Sepsis Panel TaqMan PCR Kit and the DiAGSure® Fungal Sepsis Panel TaqMan PCR Kit. The bacterial panel targets pathogens such as Methicillin-resistant Staphylococcus aureus (mecA/mecB/nuc), Vancomycin-resistant Enterococci (vanA/vanB/vanM), Streptococcus pyogenes, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. The fungal panel is designed to detect Candida species (Candida albicans, Candida tropicalis, Candida parapsilosis, Candida auris) and Aspergillus spp. 
These diagnostic tools are intended to facilitate the rapid and accurate identification of sepsis pathogens, aiding in timely and appropriate clinical interventions.